Print version ISSN 1413-8670
Braz J Infect Dis vol.14 no.1 Salvador Jan./Feb. 2010
Rosemeri Maurici da SilvaI; Maria Luiza BazzoII; Mariana ChagasIII
IPneumologist, Master in Medical Sciences and Doctor in Pneumology. Professor of the Medical School of the Universidade Federal de Santa Catarina and Universidade do Sul de Santa Catarina. Coordinator of the Program of Master's Degree in Health Sciences of the Universidade do Sul de Santa Catarina
IIDoctor in Microbiology and Professor of the Universidade Federal de Santa Catarina
IIIMaster in Pharmacy, Universidade Federal de Santa Catarina
SETTING: faster alternative techniques are required to improve the diagnosis and control of pulmonary tuberculosis.
OBJECTIVE: To evaluate the sample quality in the performance of PCR for diagnosis of pulmonary tuberculosis.
METHOD: during one year, sputum samples were collected from 72 pulmonary tuberculosis patients and 12 non-tuberculosis controls, which were admitted to the Nereu Ramos hospital, Florianópolis city, Brazil. The samples were subjected to Ziehl-Neelsen-stained sputum smear microscopy and Lowestein-Jensen medium culture, which were defined as gold standard tests for mycobacteria, and polymerase chain reaction (PCR). Those samples that presented more than 40% of viable cells and less than 25% of epithelial cells were defined as high quality samples.
RESULTS: PCR showed sensitivity of 55.6%, specificity of 41.7%, positive predictive value of 85.1%, negative predictive value of 13.5%, and accuracy of 53.6%. High quality samples showed sensitivity of 72.4%, specificity of 50%, positive predictive value of 91.3%, negative predictive value of 20%, and accuracy of 69.7%. Low quality samples showed sensitivity of 44.2%, specificity of 37.5%, positive predictive value of 79.2%, negative predictive value of 11.1%, and accuracy of 43.1%.
CONCLUSION: use of high quality samples improved significantly the PCR performance, especially on their sensitivity and positive predictive values.
Keywords: tuberculosis, sputum, polymerase chain reaction.
Pulmonary tuberculosis, despite of all knowledge gathered on its pathogenesis, epidemiology, and therapeutics over the years, remains an important public health problem in Brazil and other developing countries. Therefore, implementation of newer diagnostic methodologies and therapeutic measures are fundamental steps for the reduction of its morbidity and mortality among the patients and for stopping its transmission chain within the community.1
Presently, the identification of Mycobacterium species relies on lengthy cultures and biochemical tests. Although molecular tests are available commercially, they are restricted to certain types of patient samples or the species of Mycobacterium isolated in culture.2
Patients with few bacilli depend strongly on the sputum culture for the definitive diagnosis, which takes on average three to six weeks to be accomplished.3 Hence, faster alternative techniques are desirable, and among them, the polymerase chain reaction (PCR) seems to be the most promising.
PCR has popularized the use of molecular biology techniques in clinical laboratories for diagnosing many infectious diseases.4 However, the performance of this technique depends considerably on the quality of the samples examined. Therefore, it would be of uttermost importance to know the influence of the sample quality in its performance, as well as determining criteria for acceptability of the samples in the diagnosis using this technique.
STUDY POPULATION AND METHODS
During one year, 72 pulmonary tuberculosis inpatients of hospital Nereu Ramos, Florianópolis city, Brazil, had their sputum evaluated. In addition, twelve nontuberculosis inpatients were used as controls. The study was approved by the Human Ethic Committee of University of South of Santa Catarina, under the number 05.458.4.01.III.
The samples were collected in the morning, before breakfast, and sent as soon as possible to the laboratory. They were subjected to smear and culture for mycobacteria (both used as gold standard), and to PCR for mycobacteria.
The sputum smears were stained by the Ziehl-Neelsen technique and examined according to the guidelines of the World Health Organization.5 Briefly, heat-fixed sputum was stained with hot carbol fuchsin, decolorized with acid alcohol and then counterstained with methylene blue.
Culture of mycobacteria in Löwenstein-Jensen (LJ) medium
The samples were subjected to culture according the Petroff protocol.5 Briefly, the samples were mixed with NaOH 4% (v/v), thoroughly shaken, and incubated for 30 minutes at 35º-37º C. Then, sterile distilled water (v/v) was added to the sample and the suspension was neutralized with 1 N HCl, containing 0.004% of phenol red. The suspension was then centrifuged at 3,000 x g for 20 minutes, and the sediment was resuspended in 500 µL of saline. A hundred microliters of the sediment was then inoculated onto two LJ medium slopes. The tubes were incubated at 35º-37º C for up to eight weeks, when the tubes with no growth were discarded as negative.
Polymerase Chain Reaction - PCR
DNA was extracted by the alkaline lysis method.4 Briefly, the sputum was suspended in GTE (Glucose 50 mM, 10 mM EDTA, Tris/Cl PH 8.0, 0 25 mM), followed by cell lysis with SDS 1 %/NaOH 0.2 M. The suspension was neutralized with potassium acetate 3M pH 4.8-5.0. Proteinase K 20mg/mL was then added to the suspension and DNA was extracted with phenol/chloroform/ isoamyl alcohol (25:24:1). The suspension was then treated with ethanol plus sodium chloride and centrifuged. The sediment was re-suspended in 20 µL of TE (10mM Tris pH 7.4, 1 mM EDTA) and kept at -20º C until use.
The primer anti-sense MYC-264 and the primer sense F-285, which amplify a 1027 pair fragment of gene 16S rDNA from mycobacteria, were used in the PCR.6,7 The following conditions were met: 94º C for one minute, 60º C for one minute, 35 cycles of one minute at 72º C, and one final cycle of 94º C for one minute, 60º C for one minute and 72º C for ten minutes. The amplification products were electrophoresed on a 1% (w/v) agarose gel, stained by ethidium bromide (1 µg/mL) and photographed under 320 ηm ultra-violet light (HOEFER-MacroVue UV-20), using a gel photodocumentation (DOC-PRINT® Biosystems). Their approximate size was determined by comparing it with 100 pb molecular size standard (Invitrogen).
Positive controls included DNA from Calmette-Guérin bacillus (BCG) or Mycobacterium avium (ATCC-25291); negative controls included DNA from Escherichia coli (ATCC-25922) or pure water. As additional control, a PCR amplification of AFB-negative samples was done with primers specific for eubacteria ZR-244 e F-285.7
Quality of sputum samples
High quality samples were defined as those with more than 40% of viable cells and less than 25% of epithelial cells. The viability of cells and the percentage of epithelial cells were determined according to Pizzichini et al. and Lee et al., respectively.8,9
Performance of PCR
Sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of PCR were calculated by the software SPSS16.0®, using the results of culture and sputum smear as gold standard.
Thirty-three samples (39.3%) were of high quality, while fifty-one samples (60.7%) were of low quality. PCR was positive in 47 (56%) patients and negative in 37 (44%) patients. Table 1 shows the results of the PCR in high and low quality samples, respectively.
When all samples were tested together, PCR showed sensitivity of 55.6%, specificity of 41.7%, positive predictive value of 85.1%, negative predictive value of 13.5%, and accuracy of 53.6%. In samples of high quality, PCR showed a sensitivity of 72.4%, specificity 50%, positive predictive value of 91.3%, negative predictive value of 20%, and accuracy of 69.7%. In samples of low quality, PCR showed a sensitivity of 44.2%, specificity of 37.5%, positive predictive value of 79.2%, negative predictive value of 11.1%, and accuracy of 43.1% (Table 2).
The results of this study show that the quality of the sputum influences significantly the performance of PCR for the diagnosis of pulmonary tuberculosis. The selection of samples of high quality resulted in an improved PCR, especially when the sensitivity and positive predictive value parameters where taken into account. High quality samples presented sensitivity similar to that found into another study of clinical samples, which used primers specific for the IS6110 region of M. Tuberculosis.10
Low quality sputum can represent a problem in the daily diagnosis routine. At least 25% of sputum samples sent to laboratories for culture may not be adequate, since some of them are sometimes heavily contaminated with saliva, leading to great variability in results and low reliability.11,12
PCR assay reduces the time for diagnosis and may increase the detection of mycobacteria in samples with negative smear results. However, variations in the procedures of in-house PCR could explain the widely variability of the sensitivity and specificity reported in several studies.13,14,15
The influence of respiratory tract microbiota on the performance of PCR remains disputable. According to some authors, fungi and bacteria from these sites can affect the results of PCR from sputum.16 However, others have reported high PCR sensitivity and specificity for tuberculosis diagnosis, despite the fact that the samples were clearly contaminated with these microorganisms.17
In our study, we utilized only one sample for the same sputum. However, we could change this protocol, since some authors suggest that the sensitivity could be increased if the assay could be done with more samples for the same sputum.18,19
When testing the samples, we were not able to differentiate among different species of Mycobacterium because the amplified region is conserved in all species of the genus. Unlike other regions amplified, 16SrDNA expresses itself in fewer copies than the IS6110 sequences, but its amplification allows the rapid identification of subtypes by heteroduplex technique, which is in agreement with the objectives of this study.20,21,22
Besides the amplified region, other factors such as the amount of bacilli can influence the performance of PCR. In this regard, Wu et al, using nested-PRA for hsp65 gene, identified 100% of the samples with 3 + of bacilli, 95% of samples with 2 + bacilli, and only 53% of samples with 1 + or less bacilli.23
The fact that this study used sputum instead of culture may have contributed to lower results than those reported in the literature. However, the purpose of using sputum was an attempt to improve the technique efficiency in this type of sample by speeding up the diagnosis without the need for the culture.
Our results indicate that selection of samples of high quality resulted in an improvement in performance of PCR for the diagnosis of pulmonary TB, especially regarding its sensitivity and positive predictive value parameters.
This work was supported by Fundação de Apoio à Pesquisa Científica e Tecnológica do Estado de Santa Catarina (FAPESC, grant 771_911584).
1. Stop TB Partnership and WHO. Amsterdam Declaration to Stop TB, 2000 (www.stoptb.org/stop_tb_initiative/assets/documents/decla.pdf, accessed in November 2008). [ Links ]
2. Yeboah-Manu D, Yates MD, Wilson SM. Application of a simple multiplex PCR to aid in routine work of the Mycobacterium reference laboratory. J Clin Microbiol 2001; 39:4166-8. [ Links ]
3. Gallina M, Troupioti P, Rocco G, Sensalari G, Libanori E. Predicting culture results for Mycobacterium tuberculosis complex: amplified Mycobacterium tuberculosis direct test and acid-fast bacilli microscopy. Chest 2000; 118:28-32. [ Links ]
4. Sambrook J, Russell DW, Sambrook J. Molecular Cloning: a Laboratory Manual, 3rd ed. New York: Cold Spring Harbor Laboratory Press, 2001. 3 vol. [ Links ]
5. WHO/TB/2003.320 -WHO/CDS/CSR/RMD/2003.3. Guidelines for surveillance of drug resistance in tuberculosis. 2nd ed. Edited by: Aziz MA, Laszlo A, Raviglione M, Rieder H, Espinal M, Wright A. World Health Organization. Geneva: 2003. [ Links ]
6. Böddinghaus B, Rogall T, Florhr T, Blocker H, Bottger EC. Detection and identification of mycobacteria by amplification of rRNA. J Clin Microbiol 1990; 28:1751-59. [ Links ]
7. Rogall T, Flohr T, Bottger EC. Differentiation of Mycobacterium species by direct sequencing of amplified DNA. J Gen Microb 1990; 136:1915-20. [ Links ]
8. Pizzichini E, Pizzichini MMM, Efhtimiadis A, Hargreave FE, Dolovich J. Measurement of inflammatory indices in induced sputum: effects of selection of sputum to minimize salivary contamination. Eur Respir J 1996; 9:1174-80. [ Links ]
9. Lee GR, Bithel TC, Foerster J, Athens JW, Lukens JN. Hematologia Clínica de Wintrobe. São Paulo: Ed. Manole, 1998. [ Links ]
10. Araj GF, Talhouk RS, Itani LY, Jaber W, Jamaleddine GW. Comparative performance of PCR-based assay versus microscopy and culture for direct detection of M. tuberculosis in clinical specimens in Lebanon. Int J Tuberc Lung Dis. 2000; 4:877-81. [ Links ]
11. Skerrett JS. Diagnostic testing for community-acquired pneumonia. Clin Chest Med 1999; 20:531-48. [ Links ]
12. Chuard C, Fracheboud D, Regamey C. Effect of sputum induction by hypertonic saline on specimen quality. Diagn Microbiol Infect Dis 2001; 39:211-4. [ Links ]
13. Flores LL, Pai M, Colfors JR, Riley LW. In-house nucleic acid amplification tests for the detection of Mycobacterium tuberculosis in sputum species: meta-analysis and meta-regression. BMC Microbiol 2005; 5:55. [ Links ]
14. Sarmiento OL, Weigle KA, Alexander J, Weber DJ, Miller WC. Assessment by meta-analyses of PCR for diagnosis of smear-negative pulmonary tuberculosis. J Clin Microbiol 2003; 41:3233-40. [ Links ]
15. Assis NCS, Lopes ML, Cardoso NC, Costa MM, Souza CO, Lima KVB. Diagnóstico molecular da tuberculose pulmonar. J Bras Patol Med Lab 2007; 43:1-7. [ Links ]
16. Santos RMC, Ogusku MM, Miranda JM, Dos Santos MC, Salem JI. Avaliação da reação em cadeia da polimerase no diagnóstico da tuberculose pulmonar em pacientes indígenas e não indígenas. J Bras Pneumol 2006; 32:234-40. [ Links ]
17. Lima DM, Bollela VR, Jácomo BJT, Martinez R, Fonseca BAL. Identification of Mycobacterium species in contaminated cultures by polimerase chain reaction. CHEST 2005; 127:1283-8. [ Links ]
18. Kivihya-Ndugga L, Van Cleeff M, Juma E et al. Comparison of PCR with the routine procedure for diagnosis of tuberculosis on a population with high prevalence of tuberculosis and human immunodeficiency virus. J Clin Microbiol 2004; 42:1012-5. [ Links ]
19. Wijengaert SV, Dediste A, Gerard M, Vandenberg O, Zissis G. Critical nucleic acid amplification techniques to test for Mycobacterium tuberculosis in respiratory tract samples. J Clin Microbiol 2004; 42:837-8. [ Links ]
20. Tortoli E. Impact of genotypic studies on Mycobacterial taxonomy: the new Mycobacteria of the 1990s. Clin Microbiol Rev 2003; 16:319-54. [ Links ]
21. Waléria-Aleixo A, Kroon EG, Campos MAS, Marguti-Pinto ME, Bonjardim CA, Ferreira PC. Heteroduplex Mobility Assay for Rapid, Sensitive and Specific Detection of Mycobacteria. Diag Microbiol Infect Dis 2000; 36:225-35. [ Links ]
22. Bazzo ML. Método de identificação e caracterização de micobactérias para uso em diagnóstico de rotina nos laboratórios de saúde e determinação da resistência. PhD Thesis. Institute of Biological Sciences, Federal University of Minas Gerais, Brazil, 2006. [ Links ]
23. Wu TL, Chia JH, Kuo AJ, Su LH, Wu TS, Lai HS. Rapid identification of Mycobacteria from smear positive sputum samples by Nested PCR-Restriction fragment length polymorphism analysis. J Clin Microbiol 2008; 46:3591-4. [ Links ]
Dra. Rosemeri Maurici da Silva
Rua Moçambique, 852, Rio Vermelho
Florianópolis - SC CEP: 88060415
Submitted on: 08/19/2009
Approved on: 11/29/2009
We declare no conflict of interest.